Presentations

Public Talks

• Neuregulin-1 application reduces Phencyclidine-induced neurotransmitter level alterations in freely moving adult mice. Biennial Australasian Schizophrenia Conference 2013, Melbourne, Australia (14th May 2013)
• The alteration of PCP-induced behavioural changes by Neuregulin-1 – potential implications for Schizophrenia. Kioloa Neuroscience Colloquium 2012, Australian National University, Kioloa, Australia (11th March 2012)
• The Effect of Intracerebral Neuregulin-1 Application on PCP-Induced Hyperlocomotion – Potential Implications for Schizophrenia. Australian Neuroscience Society Annual Meeting 2012, Program No. ORAL-09-07; Gold Coast, Australia (31st January 2012)

Poster Presentations

• 2015
  • Engel, S. Sanz Munoz, L. Ooi (2015): Cholinergic neurons differentiated from sporadic Alzheimer’s disease patient stem cells show disease-relevant tau pathology. 8^th Annual Meeting of the Australasian Society for Stem Cell Research, Hunter Valley, Australia (8-10. November 2015)
  • Engel, S. Sanz Munoz, L. Ittner, L. Ooi (2015): Alzheimer’s disease tau pathology found in cholinergic, but not dopaminergic neurons differentiated from patient stem cells. 25^th International Society for Neurochemistry Meeting, Cairns, Australia (23-27. August 2015)
• 2014
  • Engel M., Ooi L., Huang XF., Frank E. (2014) Neuregulin-1 treatment prevents PCP-induced parvalbumin and GAD67 changes in frontal cortex neurons. Society for Neuroscience Annual Meeting, Washington, DC, USA (13-19. Nov. 2014)
  • Matosin N, Engel M., Fernandez-Enright F., Lum J. S., Andrews J. L., Huang X.-F., Newell K. A.. (2014) Alterations of mGluR5 and mGluR5 signaling partners in schizophrenia. Society for Neuroscience Annual Meeting, Washington, DC, USA (13-19. Nov. 2014)

• 2013
  • Engel M., Jenner AM., Huang X-F., Frank E. (2013): Neuregulin-1 treatment affects GABA and glutamate release after PCP co-treatment in freely moving mice. Society for Neuroscience annual meeting, San Diego, CA, USA (09-13. Nov. 2013)
  • Engel M., Huang XF., Frank E. (2013): Neuregulin-1 application reduces PCP-induced hyperlocomotion and GABA release – potential implications for schizophrenia treatment. 45th European Brain and Behaviour Society Meeting, Munich, Germany (06-09. Sept. 2013)
  • Engel M., Frank E. and Jenner AM. (2013): Quantitation of neurotransmitters and metabolites in microdialysate fluid using advanced gas chromatography-mass spectrometry (GC-MS). Program No. POS-Mon-238. Australian Neuroscience Society Annual Meeting 2013, Melbourne, Australia (03-06. Feb. 2013)
• 2012
  • Engel M., Huang X. and Frank E. (2012) Peripheral Neuregulin-1 administration suppresses PCP-induced hyperlocomotion in adult mice. Biological Psychiatry Australia Annual Meeting 2012, Melbourne, Australia (28-30. October 2012)
  • Engel M., Huang X. and Frank E. (2012) PCP-induced hyperlocomotion reduced by intracerebral Neuregulin-1 application in adult mice. FENS Forum Abstr. 2012, 1150, Barcelona, Spain (14-18. July 2012)
• 2009
  • N. Mirza, M. Engel, K. Sandager-Nielsen, M. S. Thomsen, J. K. Christensen, J. D. Mikkelsen. (2009) Effect of chronic D-Amphetamine and Phencyclidine treatment on cortical Inhibitory Interneurons. Program No. 840.12/N2. 2009 Neuroscience Meeting Planner. Chicago, IL, United States of America, (17-21. October 2009).
  • Engel M., Sandager-Nielsen K, Thomsen SM, Mirza NR. (2009) Effect of chronic D-Amphetamine and Phencyclidine treatment on Parvalbumin expressing interneurons. Journal of Psychopharmacology, 23(6) Abstract Supplement for Annual BAP conference 2009, TF08/A77, Oxford, United Kingdom (26-29. July 2009)
  • Engel M., Sandager-Nielsen K, Mirza NR. (2009) Amelioration of PCP-induced learning and memory deficits in the Morris’ water maze by selective α7 nAChR agonists. Journal of Psychopharmacology, 23(6) Abstract Supplement for Annual BAP conference 2009, TF09/A77, Oxford, United Kingdom (26-29. July 2009)